Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies
- 18 October 2008
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 876 (1) , 54-60
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand BorderEmerging Infectious Diseases, 2008
- Chemical Instability Determines the Biological Action of the ArtemisininsCurrent Medicinal Chemistry, 2007
- The Fe2+‐Mediated Decomposition, PfATP6 Binding, and Antimalarial Activities of Artemisone and Other Artemisinins: The Unlikelihood of C‐Centered Radicals as Bioactive IntermediatesChemMedChem, 2007
- Evidence for a Common Non‐Heme Chelatable‐Iron‐Dependent Activation Mechanism for Semisynthetic and Synthetic Endoperoxide Antimalarial DrugsAngewandte Chemie International Edition, 2007
- PFMDR1 AND IN VIVO RESISTANCE TO ARTESUNATE-MEFLOQUINE IN FALCIPARUM MALARIA ON THE CAMBODIAN–THAI BORDERThe American Journal of Tropical Medicine and Hygiene, 2007
- The reaction of artemisinins with hemoglobin: A unified pictureBioorganic & Medicinal Chemistry, 2006
- Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistanceTrends in Molecular Medicine, 2006
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003
- Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu)Antimicrobial Agents and Chemotherapy, 1993
- Qinghaosu (Artemisinin): an Antimalarial Drug from ChinaScience, 1985